Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersonal Group Regulatory News (PGH)

Share Price Information for Personal Group (PGH)

Share Price is delayed by 15 minutes
Get Live Data
395.00    0.00 (0.00%)
Bid:
390.00
Ask:
400.00
Spread: 10.00 (2.564%)
Market Cap: £124.45m
PGH Live PriceLast checked at - London Stock Exchange

Intraday Personal Group Share Chart

Trading Update

27 Jan 2022 07:00

RNS Number : 7659Z
Personal Group Holdings PLC
27 January 2022
 

27 January 2022

 

Personal Group Holdings plc

("the Company" or "Group")

 

Trading Update

 

Trading in line with expectations with encouraging rebound in insurance sales in H2

 

Personal Group Holdings Plc (AIM: PGH), the workforce benefits and services provider, is pleased to provide the following update for the financial year ending 31 December 2021. The Company expects to publish its results for FY 2021, together with notification of its final dividend, on 29 March 2022.

 

Financial Highlights

 

· Overall trading for FY 2021 was in line with market expectations with revenue of approximately £75m (2020: £72m) and adjusted EBITDA of approximately £6m (2020: £10m).

· Robust balance sheet with cash position in excess of £22m as at 31 December 2021 (2020: £20.2m).

 

Operational Highlights

 

· A strong return to face-to-face insurance sales activity in H2, with good momentum from the Group's return into Royal Mail Group in line with the contract signed in the second half of 2020.

· 86 new client wins secured in the year across the Group and continued high levels of engagement with existing clients.

· Significantly progressed our offering with the onboarding of our first client onto our new product Hapiflex, a multifaceted version of the Group's core benefits digital platform, designed to meet the need of enterprise clients.

· Continued strong performance in H2 from our pay and reward consultancy business, Innecto.

· Our consumer technology benefits business, Let's Connect, held up well in challenging circumstances around stock availability.

· Sage Employee Benefits platform continued to go from strength to strength, with the number of SME clients rising from 30 to c1,500 over the year, delivering an increased gross Annual Recurring Revenue of £1.6m.

 

Despite a longer than anticipated lockdown in H1 and continued uncertainty throughout the year the Board believes that the Group's performance in FY21 is testimony to the resilience and continued relevance of the business model and growth strategy. Solid progress has been made in achieving the Group's strategic aim to widen its footprint to multiple sectors of the UK workforce, alongside continued investment in digital channels, putting the business on track for future growth.

 

Outlook

 

Our market has never been more relevant. In 2021 employers increasingly focussed their efforts on supporting their employees, thanks to an increasingly competitive job market together with a growing appreciation of an employers' responsibility to look after staff. This trend is set to continue accelerating into 2022.

 

This has been demonstrated in the good start we have made to the current financial year. Despite the disruption of the Omicron variant in the early part of January, our face-to-face insurance sales have continued unabated, and we have seen 11 new client wins across the Group.

 

With a strong balance sheet, quality customer base and leading technology platform we are well placed to capitalise on opportunities that arise as employee health and wellbeing rises further up the Board agenda and we look to the future with confidence.

 

Deborah Frost, Chief Executive of Personal Group, commented:

 

"I am delighted with what we achieved strategically in 2021 with each business division demonstrating its ongoing relevance to employers while continued innovation underpins faster and broader growth in the future. We have a diverse range of offerings available with propositions suitable for every type of UK business, whether that be a large enterprise, a public sector organisation, or an SME.

 

Looking forward, our growth ambitions remain front of our minds and we are pleased to have begun FY22 strongly with further new client wins and exciting partnerships in play. We have a compelling offering, a leading software platform and an excellent team in place and are fully focused on executing our plans to create value for all our stakeholders."

 

 

-ENDS-

 

 

For more information please contact:

 

 

Personal Group Holdings Plc

Deborah Frost (CEO) / Sarah Mace (CFO)

Via Alma PR

Cenkos Securities Plc

Camilla Hume / Callum Davidson (Nomad)

+44 (0)20 7397 8900

Russell Kerr (Sales)

Alma PR

+44 (0)20 3405 0205

Susie Hudson / Lily Soares Smith / Faye Calow

personalgroup@almapr.co.uk

 

 

Notes to Editors

Personal Group Holdings Plc (AIM: PGH) is an employee benefits and services provider. The Group enables employers across the UK to improve employee engagement and support their people's physical, mental, social and financial wellbeing. Its vision is to create a brighter future for the UK workforce.

Personal Group provides health insurance services and a broad range of employee benefits, engagement, and wellbeing products. Its offerings can also be delivered through its proprietary app, Hapi, and the recently developed extension to the platform, Hapiflex.

The Group's growth strategy is centred around widening the footprint of the business into the SME, talent-led & Public Sectors, thereby expanding the addressable customer base. In addition, it aims to grow in its existing industrial heartlands, to re-invigorate growth in insurance policyholders and to drive the use of its SaaS offerings.

Clients include: Arsenal FC, Barchester Healthcare, Merseyrail, Randstad, Royal Mail Group, The Royal Mint, the Sandwell & Birmingham NHS Trust, Stagecoach Group plc., and The University of York. c.40% of clients are served by two or more group companies.

For further information on the Group please see www.personalgroup.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGGGUPPGRQ
Date   Source Headline
28th May 20263:51 pmRNSGrant of LTIP
12th May 20263:30 pmRNSDirector/PDMR Shareholding
7th May 20264:02 pmRNSResult of AGM
7th May 20267:00 amRNSAGM Statement
23rd Apr 20267:00 amRNSExercise of Options, PDMR and Total Voting Rights
13th Apr 20267:00 amRNSAGM Notification
1st Apr 20262:00 pmRNSHolding(s) in Company
24th Mar 20267:02 amRNSPreliminary Results and Final Dividend
23rd Mar 20267:00 amRNS-RNew Insurance Partnership
12th Mar 20267:00 amRNSNotice of Analyst and Investor Presentations
5th Feb 202612:00 pmRNSHolding(s) in Company
28th Jan 202611:00 amRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update & Notice of Full Year Results
21st Jan 20262:45 pmRNSHolding(s) in Company
21st Jan 202611:00 amRNSHolding(s) in Company
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:00 pmRNSHolding(s) in Company
2nd Dec 20257:00 amRNSCFO Succession
24th Nov 20257:00 amRNSNotification of major holdings
7th Nov 20255:41 pmRNSDirector/PDMR Shareholding
30th Sep 20255:00 pmRNSHolding(s) in Company
16th Sep 20257:00 amRNSInterim Results
27th Aug 20257:00 amRNSNotice of Results and Presentations
23rd Jul 20257:00 amRNSH1 2025 Trading Update
18th Jul 202510:18 amRNSReplacement: PDMR Share Dealing
14th Jul 20254:09 pmRNSPDMR Share Dealing
27th May 20257:00 amRNS-RPGH Presenting at the Mello 2025 Conference
19th May 20255:13 pmRNSDirector/PDMR Shareholding
15th May 20253:58 pmRNSDirector/PDMR Dealings
8th May 20255:10 pmRNSResult of AGM
8th May 20257:00 amRNSAGM Trading Statement
29th Apr 202511:51 amRNSExercise of Options, PDMR Dealing and TVR
28th Apr 20255:03 pmRNSHolding(s) in Company
9th Apr 20257:00 amRNSGrant of LTIP
8th Apr 20257:00 amRNSAGM Notification
7th Apr 20254:23 pmRNSDirector/PDMR Dealings
1st Apr 20257:00 amRNSDirectorate Change
27th Mar 20257:00 amRNSPartnership Renewal & Expansion with Sage Group
25th Mar 20257:00 amRNSPreliminary Results and Final Dividend
14th Mar 20257:00 amRNSNotice of Analyst and Investor Presentation
24th Feb 20256:00 pmRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Update & Notice of Full Year Results
3rd Jan 20257:00 amRNSPDMR Share Dealing
13th Nov 20243:45 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20244:19 pmRNSNotification of major holdings
3rd Oct 20244:16 pmRNSNotification of major holdings
30th Sep 20244:25 pmRNSNotification of major holdings
24th Sep 20247:00 amRNSInterim Results
16th Sep 20247:00 amRNSNotice of Results & Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.